concentris research management gmbh
@concentris.bsky.social
Success from the start: You focus on science - we do everything else
#ProposalWriting #ProjectManagement #dissemination #communication #ConferenceServices for EU-funded and German #research projects
🌐 www.concentris.de
#ProposalWriting #ProjectManagement #dissemination #communication #ConferenceServices for EU-funded and German #research projects
🌐 www.concentris.de
Reposted by concentris research management gmbh
🌍 The AF-B-STEP Kick-off Meeting is coming up!
🗓️ 3–5 Feb 2026 | 📍 Amsterdam, NL
Three days of collaboration, science, and dialogue to shape the future of how the burden of AF is measured & treated.
Let’s start powerful 💪🫀✨
#AFBSTEP #AtrialFibrillation
@ihieurope.bsky.social
@horizoneu.bsky.social
🗓️ 3–5 Feb 2026 | 📍 Amsterdam, NL
Three days of collaboration, science, and dialogue to shape the future of how the burden of AF is measured & treated.
Let’s start powerful 💪🫀✨
#AFBSTEP #AtrialFibrillation
@ihieurope.bsky.social
@horizoneu.bsky.social
January 20, 2026 at 6:07 PM
🌍 The AF-B-STEP Kick-off Meeting is coming up!
🗓️ 3–5 Feb 2026 | 📍 Amsterdam, NL
Three days of collaboration, science, and dialogue to shape the future of how the burden of AF is measured & treated.
Let’s start powerful 💪🫀✨
#AFBSTEP #AtrialFibrillation
@ihieurope.bsky.social
@horizoneu.bsky.social
🗓️ 3–5 Feb 2026 | 📍 Amsterdam, NL
Three days of collaboration, science, and dialogue to shape the future of how the burden of AF is measured & treated.
Let’s start powerful 💪🫀✨
#AFBSTEP #AtrialFibrillation
@ihieurope.bsky.social
@horizoneu.bsky.social
Reposted by concentris research management gmbh
Prof. Peer Bork, EMBL Interim Director General, died on 16 January 2026. A remarkable scientist and leader, he played a pivotal role in MICROB-PREDICT, inspiring colleagues & mentees alike - leaving a lasting scientific legacy. Our heartfelt condolences to his family. Thank you for everything, Peer!
January 19, 2026 at 8:38 PM
Prof. Peer Bork, EMBL Interim Director General, died on 16 January 2026. A remarkable scientist and leader, he played a pivotal role in MICROB-PREDICT, inspiring colleagues & mentees alike - leaving a lasting scientific legacy. Our heartfelt condolences to his family. Thank you for everything, Peer!
Reposted by concentris research management gmbh
📺New masterclass!
‘Data repositories & their access and publication rights’ covers the history of databases, an overview of repositories used in DECISION & provides a hands-on recipe on how to make the best out of different types of data
⏯️ youtu.be/aoA0WC1yaqs
#bioinformatics
‘Data repositories & their access and publication rights’ covers the history of databases, an overview of repositories used in DECISION & provides a hands-on recipe on how to make the best out of different types of data
⏯️ youtu.be/aoA0WC1yaqs
#bioinformatics
Data repositories and their access and publication rights | Masterclass in bioinformatics
YouTube video by concentris research management
youtu.be
January 15, 2026 at 9:21 AM
📺New masterclass!
‘Data repositories & their access and publication rights’ covers the history of databases, an overview of repositories used in DECISION & provides a hands-on recipe on how to make the best out of different types of data
⏯️ youtu.be/aoA0WC1yaqs
#bioinformatics
‘Data repositories & their access and publication rights’ covers the history of databases, an overview of repositories used in DECISION & provides a hands-on recipe on how to make the best out of different types of data
⏯️ youtu.be/aoA0WC1yaqs
#bioinformatics
Reposted by concentris research management gmbh
Save the date! We look forward to our upcoming steering committee (SC) meeting from 26-27 January 2026. We’ll hear about the results in all work packages and align the consortium's efforts for the next steps in our cross-disciplinary collaboration! @easlnews.bsky.social @horizoneu.bsky.social
January 15, 2026 at 4:48 PM
Save the date! We look forward to our upcoming steering committee (SC) meeting from 26-27 January 2026. We’ll hear about the results in all work packages and align the consortium's efforts for the next steps in our cross-disciplinary collaboration! @easlnews.bsky.social @horizoneu.bsky.social
Reposted by concentris research management gmbh
🚀 Motivation boost to kick off the new year 🙂: The European Commission agreed to provide a 6-month-long extension to A-TANGO! Let's use this momentum and move forward swiftly now, so that A-TANGO can bring the much-needed G-TAK therapy for severe #AlcoholicHepatitis #cirrhosis #ACLF to the market.
January 9, 2026 at 11:14 AM
🚀 Motivation boost to kick off the new year 🙂: The European Commission agreed to provide a 6-month-long extension to A-TANGO! Let's use this momentum and move forward swiftly now, so that A-TANGO can bring the much-needed G-TAK therapy for severe #AlcoholicHepatitis #cirrhosis #ACLF to the market.
Reposted by concentris research management gmbh
🫖 Snuggle in with a cup of tea and a blanket over the holidays to read this year's MICROB-PREDICT publications - Wishing everyone relaxing winter holidays and a wonderful start into the New Year! ❄️
📖 microb-predict.eu/for-scientis...
@medblab.bsky.social
@easlnews.bsky.social
@ec.europa.eu
📖 microb-predict.eu/for-scientis...
@medblab.bsky.social
@easlnews.bsky.social
@ec.europa.eu
December 22, 2025 at 2:38 PM
🫖 Snuggle in with a cup of tea and a blanket over the holidays to read this year's MICROB-PREDICT publications - Wishing everyone relaxing winter holidays and a wonderful start into the New Year! ❄️
📖 microb-predict.eu/for-scientis...
@medblab.bsky.social
@easlnews.bsky.social
@ec.europa.eu
📖 microb-predict.eu/for-scientis...
@medblab.bsky.social
@easlnews.bsky.social
@ec.europa.eu
Reposted by concentris research management gmbh
🥂 We have good news for the holidays: The technical hold-up in the EU portal has finally been resolved & we submitted the 3rd #PeriodicReport ☺️
Wishing everyone relaxing holidays❄️
Together, we are moving from bench to bedside to bring innovative therapies to #ACLF patients
@rajivjalan.bsky.social
Wishing everyone relaxing holidays❄️
Together, we are moving from bench to bedside to bring innovative therapies to #ACLF patients
@rajivjalan.bsky.social
December 22, 2025 at 2:02 PM
🥂 We have good news for the holidays: The technical hold-up in the EU portal has finally been resolved & we submitted the 3rd #PeriodicReport ☺️
Wishing everyone relaxing holidays❄️
Together, we are moving from bench to bedside to bring innovative therapies to #ACLF patients
@rajivjalan.bsky.social
Wishing everyone relaxing holidays❄️
Together, we are moving from bench to bedside to bring innovative therapies to #ACLF patients
@rajivjalan.bsky.social
Reposted by concentris research management gmbh
🚀 AF-B-STEP launches on 01 January 2026 🚀
🌐 afbstep.eu
A global collaboration redefining atrial fibrillation (AF) - from “yes” or “no” to what really matters. We analyse data from 100,000+ people to quantify the global burden of AF - aiming to improve diagnosis, treatment and outcomes. #HeartHealth
🌐 afbstep.eu
A global collaboration redefining atrial fibrillation (AF) - from “yes” or “no” to what really matters. We analyse data from 100,000+ people to quantify the global burden of AF - aiming to improve diagnosis, treatment and outcomes. #HeartHealth
December 19, 2025 at 5:24 PM
🚀 AF-B-STEP launches on 01 January 2026 🚀
🌐 afbstep.eu
A global collaboration redefining atrial fibrillation (AF) - from “yes” or “no” to what really matters. We analyse data from 100,000+ people to quantify the global burden of AF - aiming to improve diagnosis, treatment and outcomes. #HeartHealth
🌐 afbstep.eu
A global collaboration redefining atrial fibrillation (AF) - from “yes” or “no” to what really matters. We analyse data from 100,000+ people to quantify the global burden of AF - aiming to improve diagnosis, treatment and outcomes. #HeartHealth
As the year draws to a close, we are wrapping up 2025 with gratitude, momentum, and a spirit of community at concentris. ✨
💡Curious about what’s next in 2026, and how these developments could support your work?
Read our latest #newsletter:
🔗 mailchi.mp/concentris/n...
💡Curious about what’s next in 2026, and how these developments could support your work?
Read our latest #newsletter:
🔗 mailchi.mp/concentris/n...
New calls & Project highlights from concentris
Calls opening soon *** EU Clusters in cancer prevention & environmental health, *** New QSPainRelief Database *** Important Policy Recommendations for people with Down syndrome from GO-DS21 *** Pediat...
mailchi.mp
December 19, 2025 at 9:11 AM
As the year draws to a close, we are wrapping up 2025 with gratitude, momentum, and a spirit of community at concentris. ✨
💡Curious about what’s next in 2026, and how these developments could support your work?
Read our latest #newsletter:
🔗 mailchi.mp/concentris/n...
💡Curious about what’s next in 2026, and how these developments could support your work?
Read our latest #newsletter:
🔗 mailchi.mp/concentris/n...
Reposted by concentris research management gmbh
👏 New study from Dávid Tornai and colleagues 🎉: Serum #Villin1 is a promising non-invasive marker of #GutBarrier damage in #cirrhosis and #ACLF.
It rises with severity, predicts 90-day mortality, links to #inflammation, and has been validated in an independent cohort!
📜 doi.org/10.1111/apt....
It rises with severity, predicts 90-day mortality, links to #inflammation, and has been validated in an independent cohort!
📜 doi.org/10.1111/apt....
Serum Villin‐1—A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and Validation
Serum villin-1 is a non-invasive indicator of gut barrier damage and short-term mortality in acutely decompensated cirrhosis. Incorporating villin-1 assessment into risk stratification methods improv...
doi.org
December 8, 2025 at 1:39 PM
👏 New study from Dávid Tornai and colleagues 🎉: Serum #Villin1 is a promising non-invasive marker of #GutBarrier damage in #cirrhosis and #ACLF.
It rises with severity, predicts 90-day mortality, links to #inflammation, and has been validated in an independent cohort!
📜 doi.org/10.1111/apt....
It rises with severity, predicts 90-day mortality, links to #inflammation, and has been validated in an independent cohort!
📜 doi.org/10.1111/apt....
Reposted by concentris research management gmbh
👉 In this video, Dávid Tornai (MD, PhD) from Maria Papp's group at the University of Debrecen in Hungary presents the consortium's research on serum #villin-1, a tell-tale sign of #GutBarrier failure in cirrhotic patients with acute #decompensation via a graphical abstract.
📽️ youtu.be/URerer6AxxY
📽️ youtu.be/URerer6AxxY
MICROB-PREDICT - Serum villin-1, a tell-tale sign of gut-barrier failure in cirrhosis (Dávid Tornai)
YouTube video by concentris research management
youtu.be
December 8, 2025 at 1:39 PM
👉 In this video, Dávid Tornai (MD, PhD) from Maria Papp's group at the University of Debrecen in Hungary presents the consortium's research on serum #villin-1, a tell-tale sign of #GutBarrier failure in cirrhotic patients with acute #decompensation via a graphical abstract.
📽️ youtu.be/URerer6AxxY
📽️ youtu.be/URerer6AxxY
Reposted by concentris research management gmbh
📽️ Now online 🎧: lnkd.in/dJuMmsc4
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
November 27, 2025 at 3:20 PM
📽️ Now online 🎧: lnkd.in/dJuMmsc4
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
Reposted by concentris research management gmbh
On Wednesday, 26 Nov, at 6 pm CET, EASL Studio hosts a new episode titled “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance”
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
November 24, 2025 at 12:05 PM
On Wednesday, 26 Nov, at 6 pm CET, EASL Studio hosts a new episode titled “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance”
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
Reposted by concentris research management gmbh
🎉 Our new #mirobiome paper in #JHEP is out! We found distinct gut #virome shifts in #ACLF - from virulent to temperate #phages - with Lactococcus A + Enterococcus B phages linked to infections & higher 90-day mortality
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
October 24, 2025 at 11:33 AM
🎉 Our new #mirobiome paper in #JHEP is out! We found distinct gut #virome shifts in #ACLF - from virulent to temperate #phages - with Lactococcus A + Enterococcus B phages linked to infections & higher 90-day mortality
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
Reposted by concentris research management gmbh
🌍 The MICROB-PREDICT team met in Münster, Germany from 1–2 October for its 14th Steering Committee Meeting!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
October 24, 2025 at 11:18 AM
🌍 The MICROB-PREDICT team met in Münster, Germany from 1–2 October for its 14th Steering Committee Meeting!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
Register for this exciting and high-calibre panel discussion on early cancer detection and the impact of artificial intelligence!
📅 15 October 2025
🕑 14 - 15:00 CEST
📍 online
Register using this link: events.teams.microsoft.com/event/1fba7a...
#oncology #MedSky #OncoSky
📅 15 October 2025
🕑 14 - 15:00 CEST
📍 online
Register using this link: events.teams.microsoft.com/event/1fba7a...
#oncology #MedSky #OncoSky
🎙️Join us for the webinar “Approaches to Early Cancer Diagnosis & the Impact of #AIinOncology”
🗣️ Moderated by Federica Zanca, EIC Programme Manager
👥 Panelists:
@phireproject.bsky.social – Massimo Alfano
@pancaid.bsky.social – @nuriamalats.bsky.social
#PANCAIM – John Hermans
#Webinar
🗣️ Moderated by Federica Zanca, EIC Programme Manager
👥 Panelists:
@phireproject.bsky.social – Massimo Alfano
@pancaid.bsky.social – @nuriamalats.bsky.social
#PANCAIM – John Hermans
#Webinar
October 8, 2025 at 3:58 PM
Register for this exciting and high-calibre panel discussion on early cancer detection and the impact of artificial intelligence!
📅 15 October 2025
🕑 14 - 15:00 CEST
📍 online
Register using this link: events.teams.microsoft.com/event/1fba7a...
#oncology #MedSky #OncoSky
📅 15 October 2025
🕑 14 - 15:00 CEST
📍 online
Register using this link: events.teams.microsoft.com/event/1fba7a...
#oncology #MedSky #OncoSky
Reposted by concentris research management gmbh
Next week: the final DECISION General Assembly in Madrid! 🎉
Celebrating 5+ years of science, collaboration, & results
@rautoupe.bsky.social @concentris.bsky.social
@navarrabiomed.bsky.social
@bioeticayderecho.bsky.social
@medblab.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social et al
Celebrating 5+ years of science, collaboration, & results
@rautoupe.bsky.social @concentris.bsky.social
@navarrabiomed.bsky.social
@bioeticayderecho.bsky.social
@medblab.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social et al
October 1, 2025 at 8:02 AM
Next week: the final DECISION General Assembly in Madrid! 🎉
Celebrating 5+ years of science, collaboration, & results
@rautoupe.bsky.social @concentris.bsky.social
@navarrabiomed.bsky.social
@bioeticayderecho.bsky.social
@medblab.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social et al
Celebrating 5+ years of science, collaboration, & results
@rautoupe.bsky.social @concentris.bsky.social
@navarrabiomed.bsky.social
@bioeticayderecho.bsky.social
@medblab.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social et al
Reposted by concentris research management gmbh
✨Final spotlight of this series: Our open access protocol on a self-medication #MouseModel of #ChronicPain that helps assess spontaneous #PainRelief & #DrugAbuse liability
🔗 doi.org/10.21769/Bio...
Cabañero et al. (2022), co-authored by Beltrán Álvarez & Rafael Maldonado
#Neuroscience #Analgesics
🔗 doi.org/10.21769/Bio...
Cabañero et al. (2022), co-authored by Beltrán Álvarez & Rafael Maldonado
#Neuroscience #Analgesics
October 3, 2025 at 6:59 PM
✨Final spotlight of this series: Our open access protocol on a self-medication #MouseModel of #ChronicPain that helps assess spontaneous #PainRelief & #DrugAbuse liability
🔗 doi.org/10.21769/Bio...
Cabañero et al. (2022), co-authored by Beltrán Álvarez & Rafael Maldonado
#Neuroscience #Analgesics
🔗 doi.org/10.21769/Bio...
Cabañero et al. (2022), co-authored by Beltrán Álvarez & Rafael Maldonado
#Neuroscience #Analgesics
Reposted by concentris research management gmbh
Reposted by concentris research management gmbh
5️⃣ García-Blanco et al. (2002): www.jci.org/articles/vie...
📖 miRNA signatures associated with vulnerability to food addiction in mice & humans
💡Common #miRNA #signatures in mice & humans may underlie vulnerability to #FoodAddiction.
💡Targeting those miRNAs may modify maladaptive eating phenotypes.
📖 miRNA signatures associated with vulnerability to food addiction in mice & humans
💡Common #miRNA #signatures in mice & humans may underlie vulnerability to #FoodAddiction.
💡Targeting those miRNAs may modify maladaptive eating phenotypes.
JCI -
miRNA signatures associated with vulnerability to food addiction in mice and humans
www.jci.org
October 3, 2025 at 6:27 PM
5️⃣ García-Blanco et al. (2002): www.jci.org/articles/vie...
📖 miRNA signatures associated with vulnerability to food addiction in mice & humans
💡Common #miRNA #signatures in mice & humans may underlie vulnerability to #FoodAddiction.
💡Targeting those miRNAs may modify maladaptive eating phenotypes.
📖 miRNA signatures associated with vulnerability to food addiction in mice & humans
💡Common #miRNA #signatures in mice & humans may underlie vulnerability to #FoodAddiction.
💡Targeting those miRNAs may modify maladaptive eating phenotypes.
Reposted by concentris research management gmbh
4️⃣ academic.oup.com/ismej/articl...
📖 Presence of #Blastocystis in #GutMicrobiota associated with decreased executive function
💡Blastocystis colonisation in the gut is associated with measurable deficits in executive #CognitiveFunction, suggesting a possible #GutBrainAxis influence on cognition.
📖 Presence of #Blastocystis in #GutMicrobiota associated with decreased executive function
💡Blastocystis colonisation in the gut is associated with measurable deficits in executive #CognitiveFunction, suggesting a possible #GutBrainAxis influence on cognition.
Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function
AbstractGrowing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in hum
academic.oup.com
October 3, 2025 at 6:22 PM
4️⃣ academic.oup.com/ismej/articl...
📖 Presence of #Blastocystis in #GutMicrobiota associated with decreased executive function
💡Blastocystis colonisation in the gut is associated with measurable deficits in executive #CognitiveFunction, suggesting a possible #GutBrainAxis influence on cognition.
📖 Presence of #Blastocystis in #GutMicrobiota associated with decreased executive function
💡Blastocystis colonisation in the gut is associated with measurable deficits in executive #CognitiveFunction, suggesting a possible #GutBrainAxis influence on cognition.
Reposted by concentris research management gmbh
3️⃣ doi.org/10.3389/fpsy...
📖 Tetrahydrocannabinol #THC exposure in #adolescence elevates #impulsivity-like behaviour in #adulthood in a self-administration mouse model
💡Young-age THC exposure may produce a lasting impulsivity increase & neurochemical changes that predispose to #AddictiveBehaviour.
📖 Tetrahydrocannabinol #THC exposure in #adolescence elevates #impulsivity-like behaviour in #adulthood in a self-administration mouse model
💡Young-age THC exposure may produce a lasting impulsivity increase & neurochemical changes that predispose to #AddictiveBehaviour.
Frontiers | THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model
Cannabis addiction is a chronically relapsing disorder lacking effective treatment. Regular cannabis consumption typically begins during adolescence, and thi...
doi.org
October 3, 2025 at 6:18 PM
3️⃣ doi.org/10.3389/fpsy...
📖 Tetrahydrocannabinol #THC exposure in #adolescence elevates #impulsivity-like behaviour in #adulthood in a self-administration mouse model
💡Young-age THC exposure may produce a lasting impulsivity increase & neurochemical changes that predispose to #AddictiveBehaviour.
📖 Tetrahydrocannabinol #THC exposure in #adolescence elevates #impulsivity-like behaviour in #adulthood in a self-administration mouse model
💡Young-age THC exposure may produce a lasting impulsivity increase & neurochemical changes that predispose to #AddictiveBehaviour.
Reposted by concentris research management gmbh
1️⃣ Del Mar Cajiao-Manrique, Maldonado & Martín-García (2023) doi.org/10.3389/fpha...
📖 A self-administration mouse model to study #CannabinoidAddiction
💡This novel #MouseModel provides a rigorous tool to study #CannabinoidAddiction & the neurobiological mechanisms of #vulnerability vs. #resilience.
📖 A self-administration mouse model to study #CannabinoidAddiction
💡This novel #MouseModel provides a rigorous tool to study #CannabinoidAddiction & the neurobiological mechanisms of #vulnerability vs. #resilience.
Frontiers | A male mouse model of WIN 55,212–2 self-administration to study cannabinoid addiction
We have established for the first time a mouse model of cannabinoid addiction using WIN 55,212-2 intravenous self-administration (0.0125 mg/kg/infusion) in C...
doi.org
October 3, 2025 at 6:04 PM
1️⃣ Del Mar Cajiao-Manrique, Maldonado & Martín-García (2023) doi.org/10.3389/fpha...
📖 A self-administration mouse model to study #CannabinoidAddiction
💡This novel #MouseModel provides a rigorous tool to study #CannabinoidAddiction & the neurobiological mechanisms of #vulnerability vs. #resilience.
📖 A self-administration mouse model to study #CannabinoidAddiction
💡This novel #MouseModel provides a rigorous tool to study #CannabinoidAddiction & the neurobiological mechanisms of #vulnerability vs. #resilience.
Reposted by concentris research management gmbh
🧬🐭👩🦰👨🦰 Translational research - from mice to humans - was central to #QSPainRelief: For better #PainRelief, safer #PainMedication and improved #ChronicPain treatment.
✅ Less pain
😵💫 Fewer side effects
☺️ Better QoL
✨ Here are 5 key papers about 🧠-mechanisms linked to #addiction #cognition #impulsivity
✅ Less pain
😵💫 Fewer side effects
☺️ Better QoL
✨ Here are 5 key papers about 🧠-mechanisms linked to #addiction #cognition #impulsivity
October 3, 2025 at 6:02 PM
🧬🐭👩🦰👨🦰 Translational research - from mice to humans - was central to #QSPainRelief: For better #PainRelief, safer #PainMedication and improved #ChronicPain treatment.
✅ Less pain
😵💫 Fewer side effects
☺️ Better QoL
✨ Here are 5 key papers about 🧠-mechanisms linked to #addiction #cognition #impulsivity
✅ Less pain
😵💫 Fewer side effects
☺️ Better QoL
✨ Here are 5 key papers about 🧠-mechanisms linked to #addiction #cognition #impulsivity